Answer
Bosutinib monohydrate is not recommended during pregnancy or in women of childbearing potential not using contraception; human pregnancy data are limited, animal studies show reproductive toxicity, and patients exposed during pregnancy should be informed of the potential hazard to the foetus.
Sources for this answer
- Bosulif 500mg Film Coated TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 31Document updated
Sources checked